Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells

Journal of Cellular Biochemistry

Volumn 73, Issue 2, 1999, Pages 259-277

  Mallery, Susan R ^a   Clark, Ying Mei ^a   Ness, Gregory M ^a   Minshawi, Omar M ^a   Pei, Ping ^a   Hohl, Charlene M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemotherapeutics; Clinical management; Glutathione; Oxidant stress; Pyridine nucleotides

Indexed keywords

ANTINEOPLASTIC AGENT; DEFEROXAMINE; DIMETHYLTHIOUREA; DOXORUBICIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; DEFEROXAMINE; DNA REPLICATION; DOXORUBICIN; GLUTATHIONE; HIV SERONEGATIVITY; HUMANS; MALE; OXIDATION-REDUCTION; SARCOMA, KAPOSI; SULFHYDRYL COMPOUNDS; THIOUREA; TUMOR CELLS, CULTURED;

EID: 0033135281     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990501)73:2<259::AID-JCB12>3.0.CO;2-3     Document Type: Article

References (56)

1. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
2. Bojes HK, Datta K, Xu J, Chin A, Simonian P, Nunez G, Kehrer JP. 1997. Bcl-xl overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal. Biochem J 325:3115-319.
3. Boise L, Gonzalez-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunez G, Thompson C. 1993. bcl-x, A bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
4. Bosanquet AG. 1986. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics. Cancer Chemother Pharmacol 17:1-10.
5. Bour ES, Ward LK, Cornman GA, Ison HC. 1996. Tumor necrosis factor α induced apoptosis in hepatocytes in long-term culture. Am J Path 148:485-495.
6. Brinkley BR, Murphy P, Richardson LC. 1967. Procedure for embedding in situ selected cells cultured in vitro. J Cell Biol 35:279-283.
7. Burry RW, Lasher RS. 1978. A quantitative electron microscopic study of synapse formation in dispersed cell cultures of rat cerebellum stained either by Os-UL or by E-PTA. Brain Res 147:1-15.
8. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hopper ML, Wyllie AH. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
9. Coukell AJ, Spencer CM. 1997. Polyethylene glycol-liposomal doxorubicin. A review of its pharmcodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 53:520-538.
10. Cutts SM, Parsons PG, Sturm RA, Phillips DR. 1996. Adriamycin-induced DNA adducts inhibit the DNA interactions of transcription factors and RNA polymerase. J Biol Chem 271:5422-5429.
11. Dawson TL, Fores GJ, Nieminen AL, Herman B, Lemasters JJ. 1993. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 264:C961-C967.
12. DeGraff W, Hahn SM, Mitchel JB, Krishna MC. 1994. Free radical modes of cytotoxicity of adriamycin and streptonigrin. Biochem Pharmacol 48:1427-1435.
13. DeGraff WG, Krishna MC, Kaufman D, Mitchell JB. 1992. Nitroxide-mediated protection against X-ray and neocarzinostatin-induced DNA damage. Free Radie Biol Med 13:479-487.
14. Doroshow JH. 1983. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res 43:4543-4551.
15. Doroshow JH. 1986. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Comm 135:330-335.
16. Ensoli B, Nakumura S, Salahuddin S, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo R. 1989. AIDS Kaposi's sarcoma derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223-226.
17. Ensoli B, Barillari G, Gallo R. 1992. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 127:147-153.
18. Eyer P, Podhradsky D. 1986. Determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem 153:57-66.
19. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA. 1993. bcl-2 Modulation of apopotosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53:3321-3326.
20. Freeman BA, Crapo JD. 1982. Biology of disease free radicals and tissue injury. Lab Invest 47:412-426.
21. Fry AM, Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, Masters JRW, Hickson ID. 1991. Relationship between topoisomerase II level and chemosensitivity in human cell lines. Cancer Res 51:6592-6595.
22. Geisbuhler T, Altschuld RA, Trewyn RW, Ansel AJ, Lamka K, Brierley GP. 1984. Adenine nucleotide metabolism and compartmentalization in isolated rat heart cells. Circ Res 54:536-546.
23. Halliwell B, Gutteridge JMC. 1986. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch Biochem Biophys 246:501-514.
24. Jacobson LP and Armenian HD. 1995. An integrated approach to the epidemiology of Kaposi's sarcoma. Curr Opin Oncol 7:450-455.
25. Kehrer JP, Lund LG. 1994. Cellular Reducing Equivalents and Oxidative Stress. Free Rad Biol Med 17:65-75.
26. Koblin DD, Tomerson BW. 1990. Dimethylthiourea, a hydroxy radical scavenger, impedes the inactivation of methionine synthase by nitrous oxide in mice. Br J Aneasthesia 64:214-223.
27. Kriegel RL, Friedman-Kein AE. 1990. Epidemic Kaposi's sarcoma. Semin Oncol 17:350-360.
28. Lee FYF, Siemann DW, Sutherland RM. 1989. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer: A possible indicator of chemosensitivity. Br J Cancer 60:291-298.
29. Liu H, Kehrer JP. 1996. The reduction of glutathione disulfide produced by t-Butyl hydroperoxide in respiring mitochondria. Free Rad Biol Med 20:433-442.
30. Lui LF. 1989. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
32. Mallery SR, Ng-Bautista CL, Lantry LE, Ness GM, Hegtvedt AK, Lazo A, Bailer RT, Hout BL, Stephens RE, Brierley GP. 1994. Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities. J Cell Biochem 56:568-581.
33. Mallery SR, Bailer RT, Hohl CM, Ng-Bautista CL, Ness GM, Linvingston BE, Hout BL, Stephens RE, Brierley GP. 1995. Cultured AIDS-related Kaposi's sarcoma cells demonstrate impaired bioenergetic adaptation to oxidant challenge: Implications for oxidant stress in AIDS-KS pathogenesis. J Cell Biochem 59:317-328.
34. Mallery SR, Landwehr DJ, Ness GM, Clark YM, Hohl CM. 1998. Thiol redox modulation of tumor necrosis factor α responsiveness in cultured AIDS-related Kaposi's sarcoma cells. 68:339-354.
35. Mallery SR, Laufman HB, Solt CW, Stephens RE. 1991. Association of cellular thiol redox status with mitogen-induced calcium mobilization and cell cycle progression in human fibroblasts. J Cell Biochem 45:82-92.
36. Mallery SR, Lantry LE, Laufman HB, Stephens RE, Brierley GP. 1993. Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. J Cell Biochem 53:360-372.
37. Mathews CK, van Holde KE. 1990. Biochemistry. Redwood City, CA: Benjamin Cummings Publishing Company, Inc. p 150-155, 510-537.
38. Meister A. 1994. Glutathione, ascorbate, and cellular protection. Cancer Res (Suppl) 54:1969s-1975s.
39. Mestdagh N, Pommery N, Saucier JM, Hecquet BB, Fournier C, Slomianny C, Teissier E. Henichart JP. 1994. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes. Anticancer Res 14:869-874.
40. Miles S. 1994. Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 6:497-502.
41. Miles S, Rezai A, Salazar-Gonzalez J, Van der Meyden M, Sevens R, Logan D, Mitsuyasu R, Laza L, Hirano L, Kishimoto L, Martinez-Nazo O. 1990. AIDS Kaposi's sarcoma-derived cells produce and respond to IL-6, Proc Natl Acad Sci USA 87:4068-4072.
42. Moore PS, Gau SJ, Cominguez G, Ceasarman E, Lungu O, Knowles DM, Garber R, Pellett PE, MeGeoch DJ, Chang Y. 1996. Primary characterization of a herpes-virus agent associated with Kaposi's sarcoma. J Virol 70:549-558.
43. Nilsson UA, Olsson LI, Carlin G, Bylund-Fellenius AC. 1989. Inhibition of lipid peroxidation by spin labels. Relationships between structure and function. J Biol Chem 264:11131-11135.
44. Northfelt DW. 1994. Treatment of Kaposi's sarcoma. Current guidelines and future perspectives. Drugs 48:569-582.
45. Olson HM, Young DM, Prieur DJ, LeRoy AF, Reagan RL. 1974. Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits. Am J Pathol 77:439-454.
46. Paranka NS, Dorr RT. 1994. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells. Anticancer Res 14:2047-2052.
47. Pitot HC. 1986. The biochemistry of neoplasia in vivo. In: Fundamentals of oncology. New York: Marcell Dekker. p. 323-346.
48. Russo A, Mitchel JB. 1985. Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modultion. Cancer Treat Rep 69:1293-2196.
49. Sarvazyan NA, Askari A, Huang W-H. 1995. Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase. Life Sci 57:1003-1010.
50. Sinha BK, Katki AG, Batist G, Cowan KH, Myer CE. 1987. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action. Biochemistry 26:3776-3781.
51. Swapan R, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G, Bhalla K. 1994. 1-β-D-Arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: Improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother Pharmacol 34:365-371.
52. Taatjes DJ, Gaudiano G, Koch T. 1997. Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/ iron, xanthine oxidase/NADH/iron, or glutathione/iron. Chem Res Toxicol 10:953-961.
53. Tappero JW, Conant MA, Wolfe SF, Berger TG. 1993. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria, and therapy. Am J Dermatol 28:371-395.
54. Unverferth DV, Magorien RD, Unverferth BP, Talley RL, Balcerzak SP, Baba N. 1981. Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration. Cancer Treat Rep 65:1093-1097.
55. Weidner N, Moore DH, Ljung BR, Waldman FM, Goodson WH, Mayall B, Chew K, Smith HS. 1993. Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade. Am J Surg Path 17:987-994.
56. Willey JC, Coy E, Brolly C, Utell MJ, Frampton MW, Hammersley J, Thilly WG, Olson D, Cairns K. 1996. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 14:262-271.